Results 51 to 60 of about 8,229 (214)

Rice bZIP11 acts as a transcriptional repressor that negatively regulates photosynthesis in response to nitrogen deficiency

open access: yesNew Phytologist, EarlyView.
Phenotypes of 43‐d‐old wild‐type (WT), Osbzip11‐KO, and OsbZIP11‐OX seedlings grown under control N and low N conditions. Summary Nitrogen (N)‐deficiency responses, which are closely linked to plant biomass and crop yield, differ between plant tissues.
Namie Ohtsuki   +4 more
wiley   +1 more source

HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review

open access: yesCurrent Oncology, 2022
Low-grade stage I endometrioid endometrial carcinomas should have an excellent prognosis, but a small subset of these cancers can relapse. The search for putative immunohistochemical prognostic markers for relapse in low-risk/low-grade endometrioid ...
Valerio Mais   +8 more
doaj   +1 more source

Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Background Autoantibodies (AAbs) against p53 develop in a fraction of patients with ovarian cancer, but the mechanisms underlying their development remain unknown. High‐grade serous carcinoma (HGSC) is the most prevalent and lethal histotype, and nearly all HGSCs exhibit TP53 mutations, although only 20%–30% evoke anti‐p53 AAbs.
Cuipeng Qiu   +8 more
wiley   +1 more source

Paraurethral Endometrioid Carcinoma Arising From Ectopic Endometriosis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Malignant transformation of endometriosis is rare and most commonly involves the ovary; transformation from paraurethral endometriosis is exceedingly rare. Case Presentation A 73‐year‐old postmenopausal woman with prior ovarian endometrioma presented with dysuria and voiding difficulty.
Keita Ogasawara   +9 more
wiley   +1 more source

HE4 Tissue Expression and Serum HE4 Levels in Healthy Individuals and Patients with Benign or Malignant Tumors:A Systematic Review

open access: yes, 2014
Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithelial ovarian cancer; however, evidence of significant overexpression of HE4 in several other human cancers is expanding. To assess the possible limitations
Karlsen, Nikoline S   +3 more
core   +1 more source

HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival [PDF]

open access: yes, 2013
We investigated the HE4 variant-specific expression patterns in various normal tissues as well as in normal and malignant endometrial tissues. The relationships between mRNA variants and age, body weight, or survival are analyzed. ICAT-labeled normal and
Fu, Alex   +19 more
core   +1 more source

Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ

open access: yesDiagnostics
Background/Objectives: Elevated expression of human epididymis protein 4 (HE4) has been observed in breast cancer and is associated with cancer progression; however, its role in ductal carcinoma in situ (DCIS) remains unclear.
Nah Ihm Kim, Min Ho Park, Ji Shin Lee
doaj   +1 more source

The Application of HE4 in Diagnosis of Gynecological Pelvic Malignant Tumor

open access: yesCancer Biology & Medicine, 2009
OBJECTIVE To investigate the value of human epididymis gene product 4 (HE4) in differential diagnosis of gynecological pelvic tumors. METHODS The level of serum HE4 in 132 women was determined.
Shuyi WANG, Lixin DONG, Hongchen LI
doaj   +1 more source

Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer. [PDF]

open access: yesPLoS ONE, 2015
Human epididymis secretory protein 4 (HE4) is a secreted glycosylated protein encoded by the WAP four-disulfide core domain 2 (WFDC2) gene, located on a chromosome 20 segment that is frequently amplified in many cancers.
Pierre-Jean Lamy   +2 more
doaj   +1 more source

Targeted Protein Degradation: From Molecular Mechanisms to Emerging Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Graphical overview of targeted protein degradation: mechanisms, molecular determinants, delivery strategies, and therapeutic development. This graphical abstract summarizes the major degradation pathways involved in targeted protein degradation, including the ubiquitin–proteasome system, endocytosis–lysosome pathway, and autophagy‐dependent degradation.
Huaijuan Guo   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy